Data protection Impressum

Personalized Medicine

From left to right: Nicolas Weber, CEO of Voltiris, Nasri Nahas, CEO of Biopôle SA, Jonas Roch, CTO of Voltiris and Pierre-Jean Wipff, Innovation and Partnerships Director at Biopôle.

Business environment

Voltiris, Limula, and Parithera secure Biopôle’s Start-Up Fund

11 October 2023

Top Stories Western Switzerland

Top Stories from Western Switzerland (July-September 2023)

27 September 2023

ONWARD’s ARC therapy helps enable people with spinal cord injury to move again.

ONWARD advances into the US Federal Health arena by helping disabled veterans

20 September 2023

Neurosoft’s recent achievements set the stage for innovative treatment methods and heightened diagnostic capabilities for severe neurological disorders.

Neurosoft breaks new ground with it pioneering brain interface technology

4 September 2023

Replacing the main building constructed in 1970, the Anna-Seiler-Haus stands out as one of Switzerland's most advanced and appealing hospital buildings.

Inselspital’s CHF 670 million Anna-Seiler-Haus to set new standards in healthcare

21 August 2023

Tau imaging with 18F-Flortaucipir PET in Alzheimer’s disease. The figure shows a prototypical tau accumulation pattern, obtained by comparing tau load of patients with Alzheimer’s disease vs healthy controls. The blue-to-white color scale indicates more pronounced tau loads, with pink-white areas representing those with the highest accumulation.

HUG and UNIGE unveil the next frontier in Alzheimer’s diagnosis

15 August 2023

The canton of Bern, with its continual focus on advancing medicine through research, technology, and collaboration, stands as destination rich in opportunities for companies aiming to grow and innovate in the fields of medicine and life sciences.

Bern’s thriving ecosystem for life sciences innovation

9 August 2023

This discovery provides insight into the complex ecosystem of the tumor microenvironment and offers a new perspective on the treatment of cancer, particularly in the field of oncology.

UNIGE researchers lead breakthrough in understanding tumor growth

8 August 2023

Since its Observer Country status since December 2015, Switzerland has participated in over 20 multinational clinical trials and infrastructure projects under the ECRIN banner, including platform trials on COVID-19.

European clinical research infrastructure bolstered as Switzerland becomes ECRIN member

5 July 2023

Innovative Western Switzeland start-ups take center stage in global awards

20 June 2023

1 … 6 7 8 9 10 11 12 13 14 … 17